NEUCYTE Trademark

Trademark Overview

On Wednesday, August 3, 2016, a trademark application was filed for NEUCYTE with the United States Patent and Trademark Office. The USPTO has given the NEUCYTE trademark a serial number of 87126222. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, March 7, 2024. This trademark is owned by Neucyte, Inc.. The NEUCYTE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug identification and development services; pharmaceutical drug development services in the field of neurological disorders
neucyte

General Information

Serial Number87126222
Word MarkNEUCYTE
Filing DateWednesday, August 3, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, March 7, 2024
Registration Number5318216
Registration DateTuesday, October 24, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2016

Trademark Statements

Goods and ServicesPharmaceutical drug identification and development services; pharmaceutical drug development services in the field of neurological disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 8, 2016
Primary Code042
First Use Anywhere DateMonday, November 2, 2015
First Use In Commerce DateMonday, November 2, 2015

Trademark Owner History

Party NameNeucyte, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043
Party NameNeucyte, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306
Party NameNeucyte, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306

Trademark Events

Event DateEvent Description
Thursday, March 7, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, March 7, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, March 7, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 15, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, October 24, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 24, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, September 21, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, September 20, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 5, 2017STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 15, 2017USE AMENDMENT FILED
Saturday, September 2, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 15, 2017TEAS STATEMENT OF USE RECEIVED
Wednesday, August 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 14, 2017SOU EXTENSION 1 GRANTED
Monday, August 14, 2017SOU EXTENSION 1 FILED
Monday, August 14, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, February 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 27, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2016PUBLISHED FOR OPPOSITION
Wednesday, December 7, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 15, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 14, 2016ASSIGNED TO EXAMINER
Monday, August 8, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 6, 2016NEW APPLICATION ENTERED

Related Keywords

neucyte services pharmaceutical development drug disorders neurological field identification